Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.
about
Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for eliminationIvermectin for onchocercal eye disease (river blindness)Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary studyAssessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectinTreatment of cutaneous larva migrans.Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported casesChemotherapy for lymphatic filariasis: progress but not perfection.Treatment strategies underpinning the global programme to eliminate lymphatic filariasis.Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future.Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells.Current practices in the management of lymphatic filariasis.Adverse reactions to the ivermectin treatment of onchocerciasis patients: does infection with the human immunodeficiency virus play a role?Independent evaluation of onchocerciasis rapid assessment methods in Benue State, Nigeria.Drug of the month: ivermectin.Ivermectin influence on the mast cell activity in nodules of onchocerciasis patients.Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico.Two new tenvermectins from a genetically engineered strain Streptomyces avermitilis MHJ1011.Crusted (Norwegian) scabies in a patient with dystrophic epidermolysis bullosa.The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug.
P2860
Q21093305-0A4B9DCA-6EE4-4A01-B7CD-799C6EAFDA12Q24201374-8321A24E-78A2-465C-8DE5-740BCD1A9848Q24804532-B6062FBE-142F-4622-98DD-775E9B7BF9BFQ25257764-BD64ACCB-C70F-47A4-B346-F54682EEF8A1Q33921378-185EA05D-2E2F-43D9-992C-FBFC9BA2504AQ35671648-E7EE1215-A221-43D5-B42B-65E21B42D74BQ35917282-8BD81D1E-6D87-44A9-ADE7-C8C64E54A5FFQ36066068-29CEF45D-515D-4514-B859-F903D067670AQ36287263-16BB3C08-B931-4163-9465-63930A6865A4Q37166985-7FB9281F-F173-4637-B433-051A9DBCC402Q37503357-FE14D748-E819-47C6-8AF6-CE1C1CAC8108Q38880808-8C28AE94-094E-4684-A565-943021EA4CC9Q39591064-E26137A8-26DC-4264-A7CC-7AB6B3B79E27Q39591093-DFA6D354-6ABC-4B8D-8F78-32509E9C199AQ39593252-42E269D7-FFEE-47EC-9A9E-82FCEE24541DQ42102770-02478289-FD1A-41FD-B955-E93D8ECB0B9AQ46024994-075C96D0-C3C6-4371-89A2-8AA3C2F34310Q50644044-32DA4F8C-B6F6-4AEC-85EB-D3E228CE6087Q51283441-4DC38A16-ACD2-4F76-9B0E-94352BCB0CF3Q52574766-47FB76E8-33FC-45C6-A7E1-3DEC5D6F3346Q52670829-A2B536E7-5065-4942-8FBA-7572C38FA27C
P2860
Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Ivermectin. A review of its an ...... al efficacy in onchocerciasis.
@ast
Ivermectin. A review of its an ...... al efficacy in onchocerciasis.
@en
type
label
Ivermectin. A review of its an ...... al efficacy in onchocerciasis.
@ast
Ivermectin. A review of its an ...... al efficacy in onchocerciasis.
@en
prefLabel
Ivermectin. A review of its an ...... al efficacy in onchocerciasis.
@ast
Ivermectin. A review of its an ...... al efficacy in onchocerciasis.
@en
P2093
P1433
P1476
Ivermectin. A review of its an ...... al efficacy in onchocerciasis.
@en
P2093
P304
P356
10.2165/00003495-199142040-00007
P577
1991-10-01T00:00:00Z
P6179
1031221676